BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17510186)

  • 21. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.
    Prieto D; Buus CL; Mulvany MJ; Nilsson H
    Br J Pharmacol; 2000 Apr; 129(8):1689-99. PubMed ID: 10780975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y.
    Bischoff A; Freund A; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):635-40. PubMed ID: 9402044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
    Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
    Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.
    Racchi H; Schliem AJ; Donoso MV; Rahmer A; Zúñiga A; Guzmán S; Rudolf K; Huidobro-Toro JP
    Eur J Pharmacol; 1997 Jun; 329(1):79-83. PubMed ID: 9218687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of norepinephrine and ATP in sympathetically evoked vasoconstriction in rat tail and hindlimb in vivo.
    Johnson CD; Coney AM; Marshall JM
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2432-40. PubMed ID: 11709409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympathetic stimulation elicits increased or decreased VO2 in the perfused rat hindlimb via alpha 1-adrenoceptors.
    Hall JL; Ye JM; Clark MG; Colquhoun EQ
    Am J Physiol; 1997 May; 272(5 Pt 2):H2146-53. PubMed ID: 9176280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans.
    Stephens DP; Saad AR; Bennett LA; Kosiba WA; Johnson JM
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1404-9. PubMed ID: 15165988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooling-evoked hemodynamic perturbations facilitate sympathetic activity with subsequent myogenic vascular oscillations via alpha2-adrenergic receptors.
    Lin YH; Liu YP; Lin YC; Lee PL; Tung CS
    Physiol Res; 2017 Jul; 66(3):449-457. PubMed ID: 28248541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptors involved in nerve-mediated vasoconstriction in small arteries of the rat hepatic mesentery.
    Phillips JK; McLean AJ; Hill CE
    Br J Pharmacol; 1998 Aug; 124(7):1403-12. PubMed ID: 9723951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y and mesenteric sympathetic vasoconstriction in pregnant and non-pregnant Wistar-Kyoto rats.
    Chu ZM; Beilin LJ
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):630-2. PubMed ID: 9673442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock.
    Qureshi NU; Dayao EK; Shirali S; Zukowska-Grojec Z; Hauser GJ
    Regul Pept; 1998 Sep; 75-76():215-20. PubMed ID: 9802412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic and parasympathetic interaction in vascular and secretory control of salivary glands in anaesthetised dogs.
    McCloskey MJ; Potter EK
    Auton Neurosci; 2000 Oct; 84(1-2):50-7. PubMed ID: 11109989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.